{"schema_version":"secwatch.filing_event.v1","accession":"0001299130-24-000185","form_type":"8-K","ticker":"PACB","cik":"0001299130","company_name":"PACIFIC BIOSCIENCES OF CALIFORNIA, INC.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.010668+00:00","generated_at":"2026-05-30T01:36:48.451612+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pacific Biosciences CCO Jeff Eidel to depart Nov 15 amid commercial restructuring","bullets":["Jeff Eidel notified of separation as Chief Commercial Officer on November 11, 2024.","Separation effective November 15, 2024, due to internal restructuring of commercial organization.","Eidel's responsibilities reallocated to CEO Christian Henry; no compensation increase for Henry."],"urls":{"canonical":"https://secwatch.observer/filing/0001299130-24-000185","json":"https://secwatch.observer/filing/0001299130-24-000185.json","markdown":"https://secwatch.observer/filing/0001299130-24-000185.md","text":"https://secwatch.observer/filing/0001299130-24-000185.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000185/0001299130-24-000185-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000185/pacb-20241111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:36:48.451612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f958845aea","claim":"Jeff Eidel departed as Chief Commercial Officer at PACIFIC BIOSCIENCES OF CALIFORNIA, INC..","evidence_excerpt":"On November 11, 2024, Pacific Biosciences of California, Inc. (the “Company”) notified Jeff Eidel that, in connection with an internal restructuring of the commercial organization, he would separate from his position as the Chief Commercial Officer on November 15, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1299130/000129913024000185/0001299130-24-000185-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}